TBC Merck Sharp & Dohme (Australia) Pty Ltd
Product name
TBC
Accepted date
Jan-2024
Active ingredients
Pneumococcal purified capsular polysaccharides
Proposed indication
Active immunisation for the prevention of pneumococcal disease in adults.
Application type
A (new medicine)
Publication date
Jan-2024